AMD Agrees to Buy Rival Chip Maker Xilinx for $35 Billion
Advanced Micro Devices plans to buy rival chip maker Xilinx in a $35 billion deal, adding momentum to the consolidation of the semiconductor industry that has only accelerated during the pandemic.
Pandemic Dents Third-Quarter Sales for Pfizer
The Covid-19 pandemic weighed down sales for some drugs in the latest quarter as the company's candidate vaccine for the virus that has caused the public-health crisis continues in a large late-stage trial.
Caterpillar's Sales Fall as Coronavirus Weighs on Industry
Slower construction of everything from cruise ships to pipelines during the coronavirus pandemic is weighing on demand for Caterpillar Inc.'s heavy machinery.
Harley-Davidson Lifts Profit Amid Turnaround Push
The motorcycle manufacturer reported a stronger profit and said it would exit 39 weaker-performing markets and move to a distributor model in 17 others, including in India.
3M Sales Rise From Personal-Safety, Home-Improvement Products
The manufacturer's profit fell as expenses grew and demand for products serving industries affected by the Covid-19 pandemic continued to decline.
Merck 3Q Profit Rises, Raises 2020 Adj EPS Guidance
Merck said its profit and sales for the September quarter rose as it continued to work on treatments and vaccines for Covid-19.
BP Posts Fifth Straight Quarterly Loss
U.K. energy company BP reported a fifth consecutive quarterly loss, providing the first glimpse of how major oil companies navigated the third quarter amid a prolonged slump in demand.
HSBC Shares Jump on Lower Bad-Loan Provisions
Shares in HSBC rose after the bank took fewer provisions for bad loans in the third quarter and said it might pay a "conservative" dividend, the latest global bank to strike a cautiously optimistic note on a recovery.
Lawmakers Want to Protect Local Newspapers From Google, Facebook
Some Senate Democrats are seeking to empower regulators to protect local news outlets, accusing tech giants such as Google and Facebook of "unfair business practices," according to a new committee report.
NIH Halts Study Exploring Treating Covid-19 With Lilly Antibody, Remdesivir
Federal health researchers have halted testing a combination of Eli Lilly's Covid-19 antibody drug and remdesivir in hospitalized Covid-19 patients, after an independent committee found a lack of a benefit.
(END) Dow Jones Newswires
10-27-20 0915ET